Genetic alterations in peritoneal metastatic tumors predicted the outcomes for hyperthermic intraperitoneal chemotherapy

IntroductionCytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) are considered for patients with peritoneal metastasis (PM). However, patients selection that relies on conventional prognostic factors is not yet optimal. In this study, we performed whole exome sequencing...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Quynh-Anh Nguyen, Wan-Hsuan Chou, Mao-Chih Hsieh, Che-Mai Chang, Wei-Tzu Luo, Yu-Ting Tai, Wei-Chiao Chang
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Frontiers Media S.A. 2023-04-01
Schriftenreihe:	Frontiers in Oncology
Schlagworte:	hyperthermic intraperitoneal chemotherapy (HIPEC) peritoneal metastasis whole exome sequencing (WES) somatic mutation AGAP5
Online-Zugang:	https://www.frontiersin.org/articles/10.3389/fonc.2023.1054406/full
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!